Search results
Moderna and OpenAI Collaborate To Advance mRNA Medicine
San Mateo Daily Journal· 2 weeks agoCAMBRIDGE, MA AND SAN FRANCISCO, CA / ACCESSWIRE / April 24, 2024 / Moderna, Inc. (NASDAQ:MRNA) and OpenAI today announced ...
... Patent Battle over Covid-19 Vaccines In Legal Showdown - Moderna (NASDAQ:MRNA), Pfizer...
Benzinga· 2 weeks agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Moderna, Inc. (NASDAQ:MRNA) Expected to Earn Q3 2025 Earnings of $1.30 Per Share
ETF DAILY NEWS· 6 hours agoModerna, Inc. (NASDAQ:MRNA – Free Report) – Equities research analysts at William Blair lifted their Q3 2025 EPS estimates for Moderna
Moderna seals vaccine deal with Brazil's Health Ministry By Investing.com
Investing.com· 2 weeks agoModerna , Inc. (NASDAQ:MRNA) has secured a contract with Brazil's Ministry of Health to supply 12.5...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 4 days agoThursday, Moderna Inc MRNA reported a first-quarter EPS loss of $(3.07), down from an income of...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 2 weeks agoPfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022...been...
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National...
Morningstar· 2 weeks ago"We are proud to partner with the Ministry of Health...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 4 days agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
Moderna stock closes in green after eight sessions of losses (NASDAQ:MRNA)
Seeking Alpha· 2 weeks agoMaddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) closed in green and snapped an eight-day losing...
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 2 weeks agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.